The next generation?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 17093454.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Second-generation biologics are now entering the marketplace.
Medical subject headings
- Antibodies, Monoclonal
- Drug Industry
- Erythropoietin
- Recombinant Fusion Proteins